Original language | English |
---|---|
Pages (from-to) | 510-512 |
Number of pages | 3 |
Journal | Circulation |
Volume | 143 |
Issue number | 5 |
DOIs | |
State | Published - 2 Feb 2021 |
Keywords
- diabetes mellitus
- diastole
- echocardiography, stress
- function
- sodium-glucose transporter 2 inhibitors
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus : The IDDIA Trial. / Shim, Chi Young; Seo, Jiwon; Cho, Iksung; Lee, Chan Joo; Cho, In Jeong; Lhagvasuren, Purevjargal; Kang, Seok Min; Ha, Jong Won; Han, Gyoonhee; Jang, Yangsoo; Hong, Geu Ru.
In: Circulation, Vol. 143, No. 5, 02.02.2021, p. 510-512.Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Randomized, Controlled Trial to Evaluate the Effect of Dapagliflozin on Left Ventricular Diastolic Function in Patients With Type 2 Diabetes Mellitus
T2 - The IDDIA Trial
AU - Shim, Chi Young
AU - Seo, Jiwon
AU - Cho, Iksung
AU - Lee, Chan Joo
AU - Cho, In Jeong
AU - Lhagvasuren, Purevjargal
AU - Kang, Seok Min
AU - Ha, Jong Won
AU - Han, Gyoonhee
AU - Jang, Yangsoo
AU - Hong, Geu Ru
N1 - Funding Information: The IDDIA trial was an investigator-initiated trial funded by AstraZeneca. All analyses were conducted independently, and all authors had full access to the data. The authors are fully responsible for the study design; the collection, analysis and interpretation of the data; and the writing of the manuscript. The sponsor played no role in the decision to submit the manuscript for publication. This research was also supported by a grant of the Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Republic of Korea (grant number: HI20C1566).
PY - 2021/2/2
Y1 - 2021/2/2
KW - diabetes mellitus
KW - diastole
KW - echocardiography, stress
KW - function
KW - sodium-glucose transporter 2 inhibitors
UR - http://www.scopus.com/inward/record.url?scp=85097938907&partnerID=8YFLogxK
U2 - 10.1161/CIRCULATIONAHA.120.051992
DO - 10.1161/CIRCULATIONAHA.120.051992
M3 - Article
C2 - 33186508
AN - SCOPUS:85097938907
VL - 143
SP - 510
EP - 512
JO - Circulation
JF - Circulation
SN - 0009-7322
IS - 5
ER -